January 2026 saw significant activity as UK and EU authorities advanced major initiatives affecting the use of AI, digital technologies, data governance, and cybersecurity in healthcare and life sciences. Notable developments include EMA’s and FDA joint principles on the use of AI across the medicinal product lifecycle, the European Commission’s call for evidence on the proposed amendments to the Medical Devices Regulation (EU) 2017/745 (MDR) and In Vitro Diagnostic Regulation (EU) 2017/746 (IVDR), proposals to strengthen the EU Cybersecurity Act, and important data protection interventions. In parallel, UK and EU regulators continued to focus on the safe deployment of digital tools in healthcare, including new Medicines and Healthcare products Regulatory Agency (MHRA) guidance on mental health technologies and ongoing work to refine AI governance. These updates, alongside developments in Intellectual Property (IP) and product liability, signal a rapidly evolving regulatory environment that will help to shape digital innovation and compliance expectations throughout 2026.
Automation that Moves the Needle: Increasing Cash Flow Optimization and Real-Time Visibility
By Ryvr
For today’s CXOs, cash flow has moved beyond being a finance metric reviewed after the close. It has become a leadership priority, particularly in mid-market organizations where working capital discipline directly influences resilience, growth, and risk tolerance.
Volatility across demand cycles, interest rates, and customer payment behavior has increased the cost of delayed or inaccurate…
Litigation in Lithuania
By Will Newman
Lithuania is not just famous for beautiful castles, folk music, and farmhouse beer. It is also a technology capital, economic power, and home to about three million people. And so of course it is home to commercial disputes. I have long wanted to visit, but before I could, I had the opportunity to speak with Evaldas…
When AI-Generated Evidence Enters the Courtroom: A New Legal Risk for Businesses and Litigators
By Cezary Bicki
Artificial intelligence is rapidly changing how information is created. Now it is beginning to change how evidence appears in court.
Emails that were never written. Audio recordings that were never spoken. Reports that resemble expert analysis but were produced by a machine.
Courts across the United States are confronting a challenge they were never designed…
The Pricing Pulse: Generative AI-Assisted Review Insights from the Winter 2026 eDiscovery Pricing Survey
Editor’s Note: As part of the Winter 2026 eDiscovery Pricing Survey series, conducted by ComplexDiscovery OÜ in partnership with the EDRM (Electronic Discovery Reference Model), this post explores the pricing of generative AI-assisted review — the newest and most rapidly evolving segment of the eDiscovery pricing landscape.
In this final installment, the pricing pulse enters…
The $20B Year for OTAs: Marketing at Scale in the Age of AI
By Greg Duff
Good Sunday afternoon from Seattle . . . Our weekly Online Travel Update for Friday, February 27, 2026, is below. This week’s Update features a variety of stories, including a few new perspectives on the existential threat posed by AI to the existing online travel behemoths. For reasons I cannot explain, this week’s Update features…
Would You Trade Your Data to Skip the Line?
How to take an excellent one hour expert deposition.
My biggest pet peeve is waste of time legal events. Depositions are at the top of the list. Am forever tearing my hair out when a defense lawyer says to a seasoned expert:Q I’m assuming you’ve had your deposition taken before.A Hundreds of times.Q And you probably know the rules.A I do.Q Well, let me…
Jurors sickened by Salmonella in Ice
By Bill Marler
Abstract
On August 5, 2024, the Brown County (Illinois) Health Department (BCHD) was informed by the county sheriff that numerous potential jurors being screened for an upcoming trial had reported recently experiencing a gastrointestinal illness. One week later, on August 12, a laboratory-confirmed case of Salmonella enterica serotype Agbeni infection was reported to BCHD…
The 2 ½ Minute Opening Statement: Why Aren’t You Using GenAI?
Perfection is achieved, not when there is nothing more to add, but when there is nothing left to take away.
That philosophy of reduction is exactly what GenAI can offer trial lawyers, and here’s why that matters. Indeed, I recently talked about how slow and cumbersome the process was, particularly in light of…